Sarcosine
Based on 3 publication(s) in Google Scholar
Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia.
For research use only. We do not sell to patients.
- Purity: 98.0%
- CAS No.: 107-97-1
- Formula: C3H7NO2
- Molecular Weight:89.09
-
Storage:
Store at room temperature 3 years.
In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Sarcosine
MoreAll Endogenous Metabolite Isoforms
More
Biological Activity
|
GlyT1 |
Human Endogenous Metabolite |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Albino Swiss mice weighing (25-30 g)[2]
-
Dosage:100 mg/kg, 200 mg/kg, 400 mg/kg, 800 mg/kg
-
Administration:Intraperitoneal injection
-
Result:Elevated the seizure threshold at doses of 400 mg/kg and 800 mg/kg in the MEST test in mice.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 107-97-1
-
Appearance Solid
-
Molecular Weight 89.09
-
Formula C3H7NO2
-
Color White to off-white
-
SMILES
O=C(O)CNC
-
Synonyms
N-Methylglycine; Sarcosin
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature 3 years
In solvent -80°C 2 years -20°C 1 year
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Cell Stem Cell
Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury. [Abstract]2024 Aug 21:S1934-5909(24)00285-6. PMID: 39181130 -
Gut Microbes
A 4-guanidinobutanoic acid-SLC36A1 axis drives a microbiota‒host feedback loop to regulate intestinal homeostasis. [Abstract]2026 Dec 31;18(1):2639216. PMID: 41782409 -
Adv Sci (Weinh)
Diabetes Mellitus Facilitates Gallstone Formation Through CXCR2-NETs-Mediated Liver-Bile Barrier Damage. [Abstract]2026 Apr;13(24):e19500. PMID: 41698066
Solvent & Solubility
H2O : 100 mg/mL (1122.46 mM; Need ultrasonic)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (1122.46 mM); Clear solution; Need ultrasonic
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
[1]. Katarzyna Socała, et al. Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models. Pharmacol Rep. Mar-Apr 2010;62(2):392-7. [Content Brief]
[2]. Mei-Yi Lee, et al. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials. J Biomed Sci. 2017; 24: 18. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 11.2246 mL | 56.1230 mL | 112.2460 mL | 280.6151 mL |
| 5 mM | 2.2449 mL | 11.2246 mL | 22.4492 mL | 56.1230 mL | |
| 10 mM | 1.1225 mL | 5.6123 mL | 11.2246 mL | 28.0615 mL | |
| 15 mM | 0.7483 mL | 3.7415 mL | 7.4831 mL | 18.7077 mL | |
| 20 mM | 0.5612 mL | 2.8062 mL | 5.6123 mL | 14.0308 mL | |
| 25 mM | 0.4490 mL | 2.2449 mL | 4.4898 mL | 11.2246 mL | |
| 30 mM | 0.3742 mL | 1.8708 mL | 3.7415 mL | 9.3538 mL | |
| 40 mM | 0.2806 mL | 1.4031 mL | 2.8062 mL | 7.0154 mL | |
| 50 mM | 0.2245 mL | 1.1225 mL | 2.2449 mL | 5.6123 mL | |
| 60 mM | 0.1871 mL | 0.9354 mL | 1.8708 mL | 4.6769 mL | |
| 80 mM | 0.1403 mL | 0.7015 mL | 1.4031 mL | 3.5077 mL | |
| 100 mM | 0.1122 mL | 0.5612 mL | 1.1225 mL | 2.8062 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.